Atlas Trials

Radiotherapy Alone Versus Concurrent Chemo-radiotherapy for Nasopharyngeal Carcincoma Patients With Undectable EBV DNA After One Cylce Neoadjuvant Chemotherpy

Clinical trial NCT05674305 · RECRUITING

Trial details

NCT number
NCT05674305
Sponsor
Fudan University
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Nasopharyngeal Carcinoma
Start date
2022-01-01
Primary completion
2025-01-01
Enrollment
366

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.